Faeth Therapeutics (FTH) Market Capitalization (2021 - 2026)

Faeth Therapeutics (FTH) has reported Market Capitalization for 6 consecutive years, with $141.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 1203.66% year-over-year to $141.1 million; the trailing twelve-month figure through Jun 2026 stood at $141.1 million (up 1203.66% YoY), and the FY2025 full-year result was $13.5 million, down 94.54% from the prior year.
• Market Capitalization improved to $141.1 million in Q2 2026 per FTH's latest filing, from $42.2 million in the prior quarter.
• Across five years, Market Capitalization topped out at $1.4 billion in Q1 2022 and bottomed at $10.8 million in Q2 2025.
• Historically, Market Capitalization has averaged $487.0 million across 5 years, with a median of $329.0 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization tumbled 96.53% in 2025, then surged 1203.66% in 2026.
• Over 5 years, Market Capitalization stood at $916.8 million in 2022, then tumbled by 62.21% to $346.4 million in 2023, then slipped by 28.77% to $246.8 million in 2024, then plunged by 94.54% to $13.5 million in 2025, then surged by 947.98% to $141.1 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $141.1 million, $42.2 million, and $13.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.